Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis

Published:2022-06-21 Issue:10 Volume:24 Page:1967-1975
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Zeng Baoqi¹,Jia Hao²,Gao Le³,Yang Qingqing⁴,Yu Kai¹^ORCID,Sun Feng⁴^ORCID

Affiliation:

1. Department of Science and Education Peking University Binhai Hospital Tianjin China

2. Drug Clinical Trial Institution Peking University Binhai Hospital Tianjin China

3. Department of Pharmacology and Pharmacy The University of Hong Kong Hong Kong China

4. Department of Epidemiology and Biostatistics, School of Public Health Peking University Health Science Centre Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14781

Reference41 articles.

1. Type 1 diabetes

2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

3. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus;Fullerton B;Cochrane Database Syst Rev,2014

4. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

5. The Artificial Pancreas: How Closed-Loop Control Is Revolutionizing Diabetes

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis;Diabetes, Obesity and Metabolism;2024-06-18

2. Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands;The Lancet Digital Health;2024-04

3. Closed-Loop Control, Artificial Intelligence–Based Decision-Support Systems, and Data Science;Diabetes Technology & Therapeutics;2024-03-01

4. The efficacy of glucose‐responsive insulin and glucagon delivery on exercise‐induced hypoglycaemia among adults with type 1 diabetes mellitus: A meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2023-12-27

5. Efficacy of automated insulin delivery (AID) systems in type 1 diabetes: protocol of a systematic review and network meta-analysis of outpatient randomised controlled trials;BMJ Open;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3